Explore 3 diabetes startups that raised series b funding. Access verified founder contact information and fundraising data.
Get founder emails, funding data, and company details in one CSV
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
Get verified founder emails, funding details, and company data for 3 series b diabetes companies.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked